Prudential Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 39,324 shares of AMPH stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,324

Previous 41,425 5.07%

Holding current value

$1.77 Million

Previous $1.66 Million 15.15%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$36.99 - $50.09 $77,715 - $105,239	-2,101 Reduced 5.07%	39,324 $1.91 Million
Q2 2024 Aug 13, 2024	SELL	$38.65 - $43.48 $21,605 - $24,305	-559 Reduced 1.33%	41,425 $1.66 Million
Q1 2024 May 14, 2024	SELL	$42.85 - $63.45 $43,921 - $65,036	-1,025 Reduced 2.38%	41,984 $1.84 Million
Q4 2023 Feb 13, 2024	SELL	$44.49 - $62.93 $71,006 - $100,436	-1,596 Reduced 3.58%	43,009 $2.66 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $86,605 - $123,695	-1,903 Reduced 4.09%	44,605 $2.05 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $335,916 - $548,246	9,391 Added 25.3%	46,508 $2.67 Million
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $1.95 Million - $2.64 Million	-69,616 Reduced 65.22%	37,117 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $960,764 - $1.08 Million	-34,399 Reduced 24.37%	106,733 $0
Q3 2022 Nov 04, 2022	BUY	$27.56 - $37.75 $1.41 Million - $1.93 Million	51,117 Added 56.79%	141,132 $3.97 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $271,982 - $386,107	9,130 Added 11.29%	90,015 $3.07 Million
Q1 2022 May 13, 2022	SELL	$22.96 - $36.45 $551,499 - $875,529	-24,020 Reduced 22.9%	80,885 $2.9 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $394,490 - $506,487	-21,747 Reduced 17.17%	104,905 $2.44 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $980,881 - $1.18 Million	-55,013 Reduced 30.28%	126,652 $2.41 Million
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $986,767 - $1.21 Million	-57,672 Reduced 24.1%	181,665 $3.66 Million
Q1 2021 May 12, 2021	SELL	$17.21 - $20.65 $853,237 - $1.02 Million	-49,578 Reduced 17.16%	239,337 $4.39 Million
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $1.08 Million - $1.29 Million	60,640 Added 26.56%	288,915 $5.81 Million
Q3 2020 Nov 16, 2020	BUY	$17.99 - $22.22 $1.44 Million - $1.77 Million	79,860 Added 53.81%	228,275 $4.28 Million
Q2 2020 Aug 12, 2020	BUY	$14.25 - $22.46 $1.34 Million - $2.12 Million	94,325 Added 174.39%	148,415 $3.33 Million
Q1 2020 May 12, 2020	SELL	$12.66 - $20.08 $52,450 - $83,191	-4,143 Reduced 7.11%	54,090 $802,000
Q4 2019 Feb 11, 2020	SELL	$17.07 - $20.64 $77,446 - $93,643	-4,537 Reduced 7.23%	58,233 $1.12 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $22.62 $5,850 - $6,921	-306 Reduced 0.49%	62,770 $1.24 Million
Q2 2019 Aug 08, 2019	BUY	$18.92 - $22.96 $16,460 - $19,975	870 Added 1.4%	63,076 $0
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $4,106 - $5,334	211 Added 0.34%	62,206 $0
Q4 2018 Feb 07, 2019	BUY	$17.72 - $22.51 $90,106 - $114,463	5,085 Added 8.94%	61,995 $1.23 Million
Q3 2018 Nov 07, 2018	SELL	$15.39 - $19.38 $34,935 - $43,992	-2,270 Reduced 3.84%	56,910 $0
Q2 2018 Aug 13, 2018	SELL	$14.63 - $19.6 $46,816 - $62,720	-3,200 Reduced 5.13%	59,180 $0
Q1 2018 May 04, 2018	BUY	$17.23 - $20.35 $83,565 - $98,697	4,850 Added 8.43%	62,380 $0
Q4 2017 Feb 13, 2018	SELL	$17.76 - $19.75 $107,448 - $119,487	-6,050 Reduced 9.52%	57,530 $1.11 Million
Q3 2017 Nov 02, 2017	BUY	$14.73 - $17.99 $936,533 - $1.14 Million	63,580	63,580 $1.14 Million

Others Institutions Holding AMPH

# of Institutions

283

Shares Held

35.1M

Call Options Held

57K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.21B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History